Stem cell tourism and doctors' duties to minors-a view from Canada

American Journal of Bioethics

Volumn 10, Issue 5, 2010, Pages 3-15

  Zarzeczny, Amy ^a   Caulfield, Timothy ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Duty; Medical innovation; Minor patients; Physicians; Policy; Stem cell tourism

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANADA; CHILD; CHILD WELFARE; DECISION MAKING; DOCTOR PATIENT RELATION; ETHICS; FINANCIAL MANAGEMENT; HUMAN; INFORMED CONSENT; INTERNET; JUVENILE; LEGAL ASPECT; MEDICAL TOURISM; MEDICOLEGAL ASPECT; MIDDLE AGED; MORALITY; PARENT; PHYSICIAN ATTITUDE; PSYCHOLOGICAL ASPECT; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; CANADA; CHILD; CHILD WELFARE; CHOICE BEHAVIOR; DECISION MAKING; DUTY TO WARN; HUMANS; INTERNET; LEGISLATION, MEDICAL; MARKETING OF HEALTH SERVICES; MEDICAL TOURISM; MIDDLE AGED; MINORS; MORAL OBLIGATIONS; PARENTS; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; STEM CELL TRANSPLANTATION;

EID: 77952482959     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161003702865     Document Type: Article

References (92)

1. A.C. v. Manitoba (Director of Child and Family Services), 2009 SCC 30.
2. Amariglio, N., A. Hirshberg, B. Scheithauer, et al. 2009. Donorderived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Medicine 6(2): e1000029.
3. American Academy of Pediatrics' Committee on Children with Disabilities (AAPCCD). 2001. Counseling families who choose complementary and alternative medicine for their child with chronic illness or disability. Pediatrics 107(3): 598-601.
4. Associated Press. 2008. China offers unproven medical treatments January 5. Available at: http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20080105/chinatreatment080105?sname=medExpress2007&noads= (accessed July 28, 2009).
5. B.(R.) v. Children's Aid Society ofMetropolitan Toronto, [1995] 1 S.C.R. 315, (1994), 122 D.L.R. (4th) 1, (S.C.C.).
6. Balik, R. 2009. China's controversial stem cell treatment helps blind girl see. Finding Dulcinea, March 5. Available at: http://www.findingdulcinea.com/news/science/2009/march/China-s-Controversial-Stem-Cell-Treatment-Helps-Blind-Girl-See.html (accessed March 26, 2009).
7. BBCNews. 2009. Blind boy starts China treatment. May 7.Available at: http://news.bbc.co.uk/2/hi/uk news/wales/north west/8037357.stm (accessed May 7, 2009).
8. BBC News. 2009b. The hunt for a stem cell miracle. May 19. Available at: http://newsvote.bbc.co.uk/mpapps/pagetools/print/news.bbc.co.uk/2/hi/uk news/8052227.stm?ad=1 (accessed May 19, 2009).
9. BBC News. 2009c. 'Stem cell tourism' in Germany. June 23. Available at: http://news.bbc.co.uk/2/hi/health/8115881.stm (accessed June 23, 2009).
10. BBC News. 2009d. Safety call over stem cell trips. September 3. Available at: http://news.bbc.co.uk/2/hi/health/8234206.stm (accessed September 8, 2009).
11. BBC Panorama. 2009. Stem cells and miracles. May 18. Available in some jurisdictions at: http://www.bbc.co.uk/programmes/b00kmltm (accessed June 23, 2009).
12. Bloomberg News. 2009. Study using embryonic stem cells is delayed. August 18. Available at: http://www.nytimes.com/2009/08/19/health/research/19drug.html?r=2&ref=health (accessed September 8, 2009).
13. Bridgeman, J. 2007. Parental responsibility, young children and healthcare law. Cambridge: University Press.
14. Canadian Medical Association (CMA). 2004. CMA code of ethics. Available at: http://policybase.cma.ca/PolicyPDF/PD04-06.pdf (accessed May 12, 2009).
15. Canadian Medical Association (CMA). 2008. CMA policy: Complementary and alternative medicine. Available at http://policybase.cma.ca/dbtw-wpd/Policypdf/PD08-03.pdf (accessed June 29, 2009).
16. Caulfield, T., and C. Feasby. 2001. Potions, promises and paradoxes: Complementary and alternative medicine and malpractice law in Canada. Health Law Journal 9: 183-203.
17. Child Welfare Information Gateway. 2008. Online resources for state child welfare law and policy. Available at: http://www.childwelfare.gov/systemwide/laws policies/statutes/resources.pdf (accessed June 25, 2009).
18. Children Act 1998 (c. 41) [UK].
19. Children and Young People Act 2008, A2008-19 [Australian Capital Territory].
20. Children'sAid Society of Peel Region v. B. (C), [1988]W.D.F.L. 794 (Ont. Prov. Ct. Fm. Ct. Div.).
21. CNN. 2009. Mother, son missing in forced chemotherapy case. May 20. Available at: http://www.cnn.com/2009/US/05/19/minnesota.forced.chemo/ (accessed June 23, 2009).
22. Coghlan, A. 2009. China cracks down on stem cell tourism. September 4. Available at: http://www.newscientist.com/article/dn17725-china-cracks-down-on-stem-cell-tourism.html (accessed September 8, 2009).
23. Cohen, J., and D. Eisenberg. 2002. Potential physician malpractice liability associated with complementary and integrative medical therapies. Annals of Internal Medicine 136(8): 596-603.
24. Cohen, M. 2007. Legal and risk management issues in complementary and alternative medicine. In Complementary and alternative medicine; Ethics, the patient, and the physician, ed. L. Snyder, ch. 6. Totowa, NJ: Humana Press
25. College of Physicians and Surgeons of Alberta (CPSA). CPSA bylaws: Complimentary health care therapy provided by medical practitioners. Available at: http://www.cpsa.ab.ca/Libraries/Res/Complementary Health Care Therapy CPSA Bylaws.sflb.ashx (accessed May 13, 2009).
26. Committee on Bioethics. 1997. Religious objections to medical care. Pediatrics 99: 279-281.
27. Coukell v. Yarschenko, 2003 BCSC 247.
28. Cressey, D. 2009. Ethics scrutiny needed for Chinese-European projects. Nature News Online September 4, 2009, doi: 10.1038/461157a.
29. Cyranoski, D. 2009. Stem-cell therapy faces more scrutiny in China. Nature 459: 146-147.
30. Daily Star. 2009. Stem cell hope for blind toddler. Daily Star: Latest News. April 29. Available at: http://www.dailystar.co.uk/latestnews/view/78625/Stem-cell-hope-for-blind-toddler/ (accessed April 29, 2009).
31. Doyle, A. 2001. Alternativemedicine and medicalmalpractice. Journal of LegalMedicine 22: 533-552.
32. Esmail, N. 2007. Complementary and alternative medicine in Canada: Trends in use and public attitudes, 1997-2006. Vancouver, Canada: Fraser Institute.
33. Faunce, T., and S. Bolsin. 2005. Fiduciary disclosure of medical mistakes: The duty to promptly notify patients of adverse health care events. Journal of Law and Medicine 12: 478-482.
34. Ferguson, L. 2007. Uncertainty and indecision in the legal regulation of children: TheAlbertan experience. Canadian Journal of Family Law 23: 159-214.
35. Finkelmeyer, T. 2008. Controversial 'stem cell tourism' attracts ailing Americans. The Capital Times. September 24. Available at: http://www.madison.com/tct/news/306200 (accessed June 23, 2009).
36. Freedman, A. 2002. Legal issues in alternative healthcare. Physical Medicine and Rehabilitation Clinics of North America 13: 247-258.
37. General Medical Council. 2002. Withholding and withdrawing life-prolonging treatments: Good practice in decision-making. Available at: http://www.gmc-uk.org/guidance/current/library/witholding lifeprolonging guidance.asp (accessed June 2, 2009).
38. General Medical Council. 2006. Good medical practice. Available at: http://www.gmc-uk.org/guidance/good medical practice/GMC GMP.pdf (accessed June 2, 2009).
39. Gillick v. West Norfolk and Wisbech AHA, [1985] 3 All ER 402.
40. Gilmour, J. 2002. Children, adolescents, and health care. In Canadian health law and policy, 2nd ed., eds. J. Downie, T. Caulfield, and C. Flood, ch. 7. Toronto, Canada: Butterworths.
41. Gilmour, J. 2007. Death and dying. In Canadian health law practice manual, ed. Borden Ladner Gervais LLP, ch. 8. Toronto, Canada: LexisNexis.
42. Gordon v. Greig, 2007 CanLII 1333 (Ont. S.C.).
43. Griffin, D., and D. Fitzpatrick. 2009. U.S. patients try stem cell therapy abroad. June 2. Available at: http://www.cnn.com/2009/HEALTH/06/02/stem.cell.therapy/index.html (accessed June 2, 2009).
44. Hawkins, P., and J. Ghosn. 2007. Alternative therapies. In Canadian health law practice manual, ed. Borden Ladner Gervais LLP, ch. 13. Toronto, Canada: LexisNexis.
45. Health Canada, Minister of Public Works and Government Services Canada. 1999. Child abuse: Reporting and classification in health care settings. Available at: http://www.phac-aspc.gc.ca/cmvee/publicat/pdf/child e.pdf (accessed December 10, 2008).
46. Hui, E. 2005. Doctors as fiduciaries: Do medical professionals have the right not to treat? Poiesis Prax 3: 256-276, doi: 10.1007/s10202-005-0009-9.
47. Human Genetics Commission. 2007. More Genes Direct; A report on developments in the availability, marketing and regulation of genetic tests supplied directly to the public. Available at: http://www.hgc.gov.uk/UploadDocs/DocPub/Document/More%20Genes%20Direct.pdf (accessed June 23, 2009).
48. International Society for Stem Cell Research (ISSCR). 2008. Guidelines for the clinical translation of stem cells.Available at: http://www.stammzellen.nrw.de/en/aktuelles/ISSCRGLClinicalTrans.pdf (accessed March 26, 2009).
49. International Society for Stem Cell Research (ISSCR). 2008b. Patient handbook on stem cell therapies; Appendix I of the guidelines for the clinical translation of stem cells. Available at: http://www.isscr.org/clinical trans/pdfs/ISSCRPatientHandbook.pdf (accessed June 21, 2009).
50. Jackson, E. 2006. Medical law;Text, cases andmaterials.Oxford:Oxford University Press.
51. Jones, M. 1995. Patients who refuse consent to treatment: The legal and ethical response. Health Law Review 4(1): 17-22.
52. K. v. British Columbia (Public Trustee), [1985] B.C.W.L.D. 2170 (BCCA).
53. Kerridge, I., and J. McPhee. 2004. Ethical and legal issues at the interface of complementary and conventional medicine. Medical Journal of Australia 181(3): 164-166.
54. Kiatpongsan, S., and D. Sipp. 2009. Monitoring and regulating offshore stem cell clinics. Science 323: 1564-1565.
55. Lau, D., U. Ogbogu, B. Taylor, T. Stafinski, D. Menon, and T. Caulfield. 2008. Stem cell clinics online: The direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 3: 591-594.
56. Lim, L. 2008. Stem-cell therapy in China draws foreign patients. March 18. Available at: http://www.npr.org/templates/story/story.php?storyId=88123868 (accessed March 26, 2009).
57. Lindvall, O., and I. Hyun. 2009. Medical innovation vs. stem cell tourism. Science 324: 1664-1665.
58. Litman, M. 2007. Fiduciary law in the hospital context: The prescriptive duty of protective intervention. Health Law Journal 15: 295-352.
59. Loo, S., N. Bala, M. Clarke, and J. Hornick; Public Health Agency of Canada; Minister of Public Works and Government Services Canada. 1999. Child abuse: Reporting and classification in health care settings. Available at: http://www.phac-aspc.gc.ca/cmvee/publicat/rclass-eng.php (accessed March 26, 2009).
60. MacGregor v. Stone, [2005]W.D.F.L. 4384, [2005]W.D.F.L. 4398 (Ont. C.A).
61. McGuire, A.,M. Cho, S. McGuire, and T. Caulfield. 2007. The future of personal genomics. Science 317(5845): 1687.
62. McGuire, A., C. Diaz, T. Wang, and S. Hilsenbeck. 2009. Social networkers' attitudes toward direct-to-consumer personal genome testing. American Journal of Bioethics 9(6-7): 3-10.
63. McInerney v. MacDonald (1992), 93 D.L.R. (4th) 415 (S.C.C.).
64. Michalowski, S. 2001. Reversal of fortune-Re A (conjoined twins) and beyond: Who should make treatment decisions on behalf of young children? Health Law Journal 9: 149-169.
65. Moss, L. 2009. Warning over 'stem cell tourists.' February 23.Available at: http://www.scotsman.com/latestnews/Warningover-39stemcell-tourists39.4995013.jp (accessed February 23, 2009).
66. Nelson, B. 2008. Stem cell researchers face down stem cell tourism. Nature Reports Stem Cells. Online June 5: doi: 10.1038/stemcells.2008.89.
67. Ogilvie, M. 2008. 'Stem cell tourism' is exploitation, experts say. July 28. Available at: http://www.thestar.com/living/article/468348 (accessed June 23, 2009).
68. Perotin, M. 2009. Lured by promise of stem cells, Americans head abroad for medical treatment. February 9. Available at: http://www.physorg.com/news153377258.html (accessed June 23, 2009).
69. Picard, E., and G. Robertson. 2007. Legal liability of doctors and hospitals in Canada, 4th ed. Toronto: Thomson Carswell.
70. Prasad, A., and M. Veĺasquez. 2007. Advising patients and communicating about complementary and alternativemedicine. In Complementary and alternative medicine; Ethics, the patient, and the physician, ed. L. Snyder, ch. 4. Totowa, NJ: Humana Press.
71. Qiu, J. 2009. China clamps down on controversial therapies. Lancet 373: 1834-1835.
72. Qiu, J. 2009b. Trading on hope. Nature Biotechnology 27(9): 790-792.
73. Re D (TT) (1999), 171 D.L.R. (4th) 761 (SKQB).
74. Re Eve (1986), 31 D.L.R. (4th) 1 (S.C.C.).
75. Re M.M., 2007 ABPC 6.
76. Re Wyatt, [2005] 1WLR 3995 (E.W.C.A.).
77. Regenberg, A., L. Hutchinson, B. Schanker, and D. Matthews. 2009. Medicine on the fringe: Stem cell-based interventions in advance of evidence. Stem Cells 9999(999A): OnlineMay 21, 2009, doi: 10.1002/stem.132.
78. Reuters. 2009. Hungary detains 4 over illegal stem cell treatment. July 29. Available at: http://www.reuters.com/articlePrint?articleId=USLT722924 (accessed July 30, 2009).
79. Robertson, G. 2002. Negligence and malpractice. In Canadian health law and policy, 2nd ed., eds. J. Downie, T. Caulfield, and C. Flood, ch. 3. Toronto, Canada: Butterworths.
80. Royal College of Paediatrics and Child Health. 2002. Good medical practice in paediatrics and child health: Duties and responsibilities of paediatricians. London: Royal College of Paediatrics and Child Health.
81. Royal College of Paediatrics and Child Health. 2004. Witholding or withdrawing life sustaining treatment in children: A framework for practice, 2nd ed. London: Royal College of Paediatrics and Child Health.
82. Schmidt, C. 2008. Regulators weigh risks of consumer genetic tests. Nature Biotechnology 26(2): 145-146.
83. Sheldon, T. 2007. The Netherlands ban private stem cell therapy. British Medical Journal 334: 12(January 6), doi: 10.1136/bmj.39072.458449.DB.
84. Simms v. An NHS Trust, [2002] EWHC 2734 (Fam).
85. Smith, T. 2009. Physicians oppose stem cell clinic. May 15. Available at: http://www.royalgazette.com/siftology.royalgazette/Article/article.jsp?articleId=7d957b330030001§ionId=60 (accessed May 15, 2009).
86. Stafford, N. 2009. Germany tightens law on stem cell treatments. British Medical Journal 339: b2967, doi: 10.1136/bmj.b2967.
87. Stein, R. 2009. Government approves study using embryonic stem cells. January 24. Available at: http://www.washingtonpost.com/wpdyn/content/story/2009/01/26/ST2009012601250.html (accessed March 26, 2009).
88. Templeton, S.-K. 2009. Stem cell treatment 'is child abuse.' September 6. Available at: http://www.timesonline.co.uk/tol/life and style/health/child health/article6823372.ece (accessed September 8, 2009).
89. Vaught, W. 2007. Complementary and alternative medicine; The physician's ethical obligations. In Complementary and alternative medicine; Ethics, the patient and the physician, ed. L. Snyder, ch. 3. Totowa, NJ: Humana Press.
90. Weir, M. 2003. Obligation to advise of options for treatment-medical doctors and complementary and alternative medicine practitioners. Journal of Law and Medicine 10: 296-307.
91. Wilson, J. 2009. A history lesson for stem cells. Science 324(May 8): 727-728.
92. rd General Assembly of the World Medical Association, London, England, October 1949, and amended by the 22nd World Medical Assembly Sydney, Australia, August 1968, and the 35th World Medical Assembly Venice, Italy, October 1983, and the WMA General Assembly, Pilanesberg, South Africa, October 2006. Available at: http://www.wma.net/e/policy/c8.htm (accessed May 13, 2009).